Jewell Christopher M has filed 20 insider transactions across 1 company since November 2023.
Most recent transaction: a option exercise of 9000 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 10, 2025.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 9000 | $3.23 | 62,490.0000 | 25,767,369 | 16.83% | 0.03% |
| Jan. 10, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 9000 | $0.00 | 67,432.0000 | 25,767,369 | 11.78% | 0.03% |
| Jan. 3, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 1264 | $16.72 | 54,776.0000 | 25,767,369 | 2.26% | 0.00% |
| Jan. 6, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 1286 | $16.83 | 53,490.0000 | 25,767,369 | 2.35% | 0.00% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | A | Common Stock | 16100 | $0.00 | 56,040.0000 | 25,767,369 | 40.31% | 0.06% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 47400 | $0.00 | 47,400.0000 | 25,767,369 | 9999.99% | 0.18% |
| Nov. 20, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 14000 | $3.23 | 39,940.0000 | 23,896,525 | 53.97% | 0.06% |
| Nov. 20, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 14000 | $0.00 | 76,432.0000 | 23,896,525 | 15.48% | 0.06% |
| Nov. 14, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 36050 | $3.23 | 61,990.0000 | 23,896,525 | 138.97% | 0.15% |
| Nov. 14, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 18550 | $16.34 | 43,440.0000 | 23,896,525 | 29.92% | 0.08% |
| Nov. 14, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 17500 | $17.02 | 25,940.0000 | 23,896,525 | 40.29% | 0.07% |
| Nov. 15, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Common Stock | 16065 | $3.23 | 42,005.0000 | 23,896,525 | 61.93% | 0.07% |
| Nov. 15, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | S | Common Stock | 16065 | $17.06 | 25,940.0000 | 23,896,525 | 38.25% | 0.07% |
| Nov. 14, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 36050 | $0.00 | 106,497.0000 | 23,896,525 | 25.29% | 0.15% |
| Nov. 15, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 16065 | $0.00 | 90,432.0000 | 23,896,525 | 15.08% | 0.07% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4276 | $0.00 | 33,265.0000 | 5,515,836 | 11.39% | 0.08% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | M | Stock Option (Right to Buy) | 142547 | $0.00 | 175,812.0000 | 5,515,836 | 428.52% | 2.58% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | A | Common Stock | 778200 | $0.00 | 778,200.0000 | 5,397,597 | 9999.99% | 14.42% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 998000 | $0.00 | 998,000.0000 | 5,397,597 | 9999.99% | 18.49% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Jewell Christopher M | Chief Scientific Officer | A | Stock Option (Right to Buy) | 4276 | $0.00 | 4,276.4540 | 5,101,459 | 9999.99% | 0.08% |